Leo Foundation's new CIO looks forward to life without MIFID II

At the start of October, a top member of Danske Capital's team swapped his job at the Danish banking group for the foundation that owns Danish drugmaker Leo Pharma. The limits of MIFID II are now a thing of the past, says Morten Stampe Christensen.

Morten Stampe Christensen, new CIO at Leo Foundation. Photo: LEO Foundation

Log in to read our articles

Welcome to AMWatch. A part of our content is exclusive and reserved for our users.

Try AMWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles

amwatch trial

Latest news


See all

See all

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch